Hilbers U, Peters J, Bornstein S R, Correa F M, Jöhren O, Saavedra J M, Ehrhart-Bornstein M
Department of Internal Medicine III, University of Leipzig, Germany.
Hypertension. 1999 Apr;33(4):1025-30. doi: 10.1161/01.hyp.33.4.1025.
NCI-H295, a human adrenocarcinoma cell line, has been proposed as a model system to define the role of the renin-angiotensin system in the regulation of aldosterone production in humans. Because the precise cellular localization of the components of the renin-angiotensin system in human adrenal cortical cells remains unclear, we investigated their localization in this defined cell system. NCI-H295 cells expressed both angiotensinogen and renin as shown by reverse transcriptase polymerase chain reaction and immunohistochemistry. Human angiotensin-converting enzyme (ACE) was not detectable by immunocytochemistry, ACE binding, or reverse transcriptase polymerase chain reaction. However, 3.5 mmol/L K+ stimulated the formation of both angiotensin I and angiotensin II 1. 9- and 2.5-fold, respectively, and increased aldosterone release 3. 0-fold. The K+-induced stimulation of aldosterone release was decreased by captopril and enalaprilat (24% and 26%, respectively) and by the angiotensin type 1 (AT1)-receptor antagonist losartan (28%). Angiotensin II-induced stimulation of aldosterone release was abolished by losartan treatment. Specific [125I]Sar1-angiotensin II binding was detected by receptor autoradiography. The binding of [125I]Sar1-angiotensin II was completely displaced by the AT1 antagonist losartan but not by the AT2 receptor ligand PD 123319, confirming the expression of angiotensin II AT1 receptors in NCI-H295 cells. Our results demonstrate that NCI-H295 cells express most of the components of the renin-angiotensin system. Our failure to detect ACE, however, suggests that the production of angiotensin II in NCI-H295 cells may be ACE independent. NCI-H295 cells are able to produce angiotensin II, and K+ increases aldosterone secretion in part through an angiotensin-mediated pathway. The production of angiotensin II in NCI-H295 cells demonstrates that this human cell line can be useful to characterize the role of locally produced angiotensin II in the regulation of aldosterone release.
NCI-H295是一种人肾上腺癌细胞系,已被提议作为一个模型系统,用于确定肾素-血管紧张素系统在人类醛固酮生成调节中的作用。由于肾素-血管紧张素系统各成分在人肾上腺皮质细胞中的精确细胞定位尚不清楚,我们在这个明确的细胞系统中研究了它们的定位。逆转录聚合酶链反应和免疫组织化学显示,NCI-H295细胞同时表达血管紧张素原和肾素。免疫细胞化学、ACE结合或逆转录聚合酶链反应均未检测到人血管紧张素转换酶(ACE)。然而,3.5 mmol/L的钾离子分别刺激血管紧张素I和血管紧张素II的生成增加1.9倍和2.5倍,并使醛固酮释放增加3.0倍。卡托普利和依那普利拉(分别为24%和26%)以及血管紧张素1型(AT1)受体拮抗剂氯沙坦(28%)可降低钾离子诱导的醛固酮释放刺激。氯沙坦处理可消除血管紧张素II诱导的醛固酮释放刺激。通过受体放射自显影检测到特异性的[125I]Sar1-血管紧张素II结合。[125I]Sar1-血管紧张素II的结合被AT1拮抗剂氯沙坦完全取代,但未被AT2受体配体PD 123319取代,这证实了NCI-H295细胞中血管紧张素II AT1受体的表达。我们的结果表明,NCI-H295细胞表达肾素-血管紧张素系统的大部分成分。然而,我们未能检测到ACE,这表明NCI-H295细胞中血管紧张素II的产生可能不依赖于ACE。NCI-H295细胞能够产生血管紧张素II,钾离子部分通过血管紧张素介导的途径增加醛固酮分泌。NCI-H295细胞中血管紧张素II的产生表明,这种人类细胞系可用于表征局部产生的血管紧张素II在醛固酮释放调节中的作用。